Related Experiment Video
Updated: Nov 26, 2025
07:13
Modified Experimental Conditions for Noise-Induced Hearing Loss in Mice and Assessment of Hearing Function and Outer Hair Cell Damage
Published on: February 10, 2023
2.6K
Increased atherogenic index in the general hearing loss population
Huai Zhang1, Dahui Wang1, Haiyan Ma1
1The Medical School, Hangzhou Normal University, Hangzhou, Zhejiang, China.
Open Medicine (Warsaw, Poland)
|December 14, 2020
Summary
Atherogenic index (AI) is linked to hearing loss in the general population. Young and middle-aged women show the strongest connection between higher AI and increased hearing loss risk.
Area of Science:
- Cardiovascular Health
- Audiology
- Public Health
Background:
- Hearing loss is a growing public health concern.
- The atherogenic index (AI) is a marker of cardiovascular risk.
- The relationship between AI and hearing loss in the general population requires further investigation.
Purpose of the Study:
- To investigate the association between atherogenic index (AI) and hearing loss.
- To determine if AI is a predictor of hearing impairment in a general population cohort.
Main Methods:
- A multistage cluster random sampling study was conducted in Zhejiang province (2016-2018).
- Pure-tone air-conduction hearing thresholds were measured across a wide frequency range (0.125-8 kHz).
- Plasma lipid data and participant demographics were collected for analysis.
Main Results:
- 3,414 participants were included; 32.6% had hearing loss.
- Increased AI was significantly associated with hearing loss.
- Young and middle-aged women with the highest AI quartile had the greatest risk of hearing loss.
- AI was higher in individuals with varying degrees of hearing loss, except for the extremely severe category.
Conclusions:
- The atherogenic index (AI) is positively associated with hearing loss in the general population.
- This association is particularly pronounced in young and middle-aged women.
- AI may serve as a potential indicator for hearing loss risk assessment.
More Related Videos
09:09Cryosectioning and Immunostaining Mouse Inner Ear Tissue: From Embryonic to Adult Stages
Published on: April 11, 2025
1.3K
14:05Behavioral Assessment of Hearing in 2 to 4 Year-old Children: A Two-interval, Observer-based Procedure Using Conditioned Play-based Responses
Published on: January 23, 2017
29.5K
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
677
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
677
01:26Atherosclerosis III: Management
150
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
150
01:13Therapeutic Index
6.0K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.0K
01:30Atherosclerosis I: Introduction
435
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
435
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
209
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
209
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
83
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
83